Press releases
These press releases are intended for journalists and analysts/investors.
-
Kimbra launches campaign to urge effective asthma management
Asthma Awareness Week – Popular recording artist and asthma sufferer Kimbra is joining forces with asthma experts and peak respiratory
Read more -
Medicines Research Unit to Close
GSK today announced it will be closing the Medicines Research Unit at the Prince of Wales Hospital in Sydney
Read more -
GSK Open Innovation brings opportunities to Australian & NZ innovators
Australian and New Zealand health innovators encouraged to apply for partnership with GSK to turn their ideas into reality
Read more -
GSK Response to Publication of Paracetamol in Low Back Pain Study (PACE)
Panadol is approved by the TGA for the effective relief of backache
Read more -
New medicine for lupus now available in Australia
GSK is pleased to announce that BENLYSTA® (belimumab) is now available in Australia for use as an add-on therapy in adult patients
Read more -
Incruse® Ellipta® (umeclidinium) approved in Australia for Chronic Obstructive Pulmonary Disease
GlaxoSmithKline has announced today that the Therapeutic Goods Administration (TGA) has approved Incruse® Ellipta® (umeclidinium)
Read more -
Anoro® Ellipta® approved in Australia for Chronic Obstructive Pulmonary Disease
GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) have proudly announced that the Therapeutic Goods Administration
Read more -
GSK Recognises Top Poppy Growers
Leaders in Australian poppy production, GSK awarded its top poppy producers at an award dinner held in Launceston last week
Read more -
$80,000 to local communities to boost immunisation
GSK’s 2014 Immunisation Grants for local communities were launched today at the Public Health Association of Australia’s 14th annual
Read more -
GSK Response to CHOICE Media Release
GSK has previously provided detailed product information and clinical studies to CHOICE and would like to respond to some of the allegation
Read more -
GSK Australia Reports 2013 results to ASIC
GSK Australia reported to the Australian Securities and Investment Commission (ASIC) for 2013, sales of $1,414m
Read more -
Skin Science Facility to Close in Rowville, Victoria
GSK announced today the immediate closure of the Stiefel, skin science facility in Rowville, Victoria
Read more -
2013 Corporate Responsibility Report Published
GSK Australia and New Zealand today published the second annual corporate responsibility report, outlining key achievements in health
Read more -
GSK comment: China investigation
Following media coverage today related to the investigation being conducted by the Chinese authorities into GSK China Ltd
Read more -
Positive poppy trial results encourage on-going investigation
Positive results from GSK’s 2013-14 poppy growing trials across Victoria will provide a sound foundation for more targeted trials
Read more -
GSK discloses 2013 payments to Australian healthcare professionals
As part of our ongoing commitment to increase transparency, we are disclosing today, the aggregate amount of fees paid
Read more -
GSK encourages research excellence as award nominations open
GSK has opened nominations for what is regarded as one of the most prestigious research awards available to the Australian science
Read more -
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and COPD
GSK Australia and Theravance, Inc. (NASDAQ: THRX) have proudly announced today that the Therapeutic Goods Administration (TGA)
Read more -
GSK innovation starts to relieve the urge to smoke in 50 seconds
GSK Australia launched today a new innovative product Nicabate Oral Strips that starts to* relieve the urge to smoke in just 50 seconds
Read more -
Illuminate your smile with the new Macleans® High Definition™ White range
We all know how important it is to present our best possible self, unleashing the unmistakable feeling of illumination
Read more
-
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
Products
We make a wide range of prescription medicines, vaccines and consumer healthcare products.
-
Careers
GSK is a place where talented people do amazing things. Where you are encouraged to be you and create a meaningful impact.
-
Research and development
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products.
